These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2506109)

  • 41. Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.
    Papp-Wallace KM; Bajaksouzian S; Abdelhamed AM; Foster AN; Winkler ML; Gatta JA; Nichols WW; Testa R; Bonomo RA; Jacobs MR
    Diagn Microbiol Infect Dis; 2015 May; 82(1):65-9. PubMed ID: 25737290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
    Payne DJ; Marriott MS; Amyes SG
    J Med Microbiol; 1990 Jun; 32(2):131-4. PubMed ID: 2192063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis.
    Raquet X; Lamotte-Brasseur J; Fonzé E; Goussard S; Courvalin P; Frère JM
    J Mol Biol; 1994 Dec; 244(5):625-39. PubMed ID: 7990143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
    Féria C; Ferreira E; Correia JD; Gonçalves J; Caniça M
    J Antimicrob Chemother; 2002 Jan; 49(1):77-85. PubMed ID: 11751770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictive analysis of ceftazidime hydrolysis in CTX-M-type beta-lactamase family members with a mutational substitution at position 167.
    Kimura S; Ishii Y; Tateda K; Yamaguchi K
    Int J Antimicrob Agents; 2007 Mar; 29(3):326-31. PubMed ID: 17258896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid.
    Thomson CJ; Amyes SG
    J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism.
    Bert F; Branger C; Lambert-Zechovsky N
    J Antimicrob Chemother; 2002 Jul; 50(1):11-8. PubMed ID: 12096001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemical analysis of TEM-134, a new TEM-type extended-spectrum beta-lactamase variant produced in a Citrobacter koseri clinical isolate from an Italian hospital.
    Perilli M; Celenza G; Fiore M; Segatore B; Pellegrini C; Luzzaro F; Rossolini GM; Amicosante G
    J Antimicrob Chemother; 2007 Oct; 60(4):877-80. PubMed ID: 17673478
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
    Ma L; Alba J; Chang FY; Ishiguro M; Yamaguchi K; Siu LK; Ishii Y
    Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Convergent evolution of TEM-26, a beta-lactamase with extended-spectrum activity.
    Hibbert-Rogers LC; Heritage J; Todd N; Hawkey PM
    J Antimicrob Chemother; 1994 Apr; 33(4):707-20. PubMed ID: 8056689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory activity of avibactam against selected β-lactamases expressed in an isogenic Escherichia coli strain.
    Giani T; Cannatelli A; Di Pilato V; Testa R; Nichols WW; Rossolini GM
    Diagn Microbiol Infect Dis; 2016 Sep; 86(1):83-5. PubMed ID: 27394638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
    Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
    FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel ceftazidime-hydrolysing extended-spectrum beta-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop.
    Bae IK; Lee BH; Hwang HY; Jeong SH; Hong SG; Chang CL; Kwak HS; Kim HJ; Youn H
    J Antimicrob Chemother; 2006 Aug; 58(2):315-9. PubMed ID: 16785225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB; Carias LL; Bonomo RA; Shlaes DM
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purification of beta-lactamases and enzyme kinetic studies on aztreonam.
    Zhao XJ; Li JT
    Chin Med J (Engl); 1992 May; 105(5):424-9. PubMed ID: 1499375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
    Robin F; Delmas J; Schweitzer C; Tournilhac O; Lesens O; Chanal C; Bonnet R
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1304-9. PubMed ID: 17220412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel sequence framework (bla(TEM-1G)) encoding the parental TEM-1 beta-lactamase.
    Pomba-Féria C; Caniça M
    FEMS Microbiol Lett; 2003 Mar; 220(2):177-80. PubMed ID: 12670678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases.
    Blazquez J; Morosini MI; Negri MC; Gonzalez-Leiza M; Baquero F
    Antimicrob Agents Chemother; 1995 Jan; 39(1):145-9. PubMed ID: 7695296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 beta-lactamase.
    Péduzzi J; Barthélémy M; Tiwari K; Mattioni D; Labia R
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2160-3. PubMed ID: 2694955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Site-directed mutagenesis on TEM-1 beta-lactamase: role of Glu166 in catalysis and substrate binding.
    Delaire M; Lenfant F; Labia R; Masson JM
    Protein Eng; 1991 Oct; 4(7):805-10. PubMed ID: 1798703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.